Industry Categories Healthcare Technology
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease

JUPITER, FL, UNITED STATES, May 27, 2026 — Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage biopharmaceutical company developing investigational therapies for neurodegenerative diseases, today announced that patient enrollment is now underway in its Phase 2a RESET clinical trial (NCT07592767)…
Daradia Announces 10th Batch of GE-Daradia Online Fellowship in MSK Ultrasound in Pain Medicine

